	Microbiome-urothelium crosstalk in bladder cancer: From dysbiosis to clinical translation. IMetaOmics Xu H, Li Z, Yang L, Zheng J, Li W, Liao R, Huang W, Sun B, Li Z, Ma C, Yang X, Wang Z, Zhao J, Cheng B, Wu P. PMID: 42891336 [PubMed]
	Cost-effectiveness of adding enzalutamide vs standard non-steroidal antiandrogen drugs for patients with metastatic hormone-sensitive prostate cancer undergoing standard first-line therapy: a within-trial, secondary end-point analysis of the ENZAMET phase 3, international randomized trial (ANZUP 1304). EClinicalMedicine Law CK, Stockler MR, Martin AJ, Davis ID, Sweeney CJ, Morton RL. PMID: 42890411 [PubMed]
	Multiparametric MRI-based habitat and peritumoral radiomics integrating semi-automated segmentation for preoperative prediction of high-grade prostate cancer: a dual-center study. Front Oncol Hua D, Ma L, Ji X, Huang L, Zhao Y, Shen W. PMID: 42890019 [PubMed]
	From inherited susceptibility to tumor state: toward a stage-aware architecture for genomic risk stratification in prostate cancer. Front Genet Zheng Z, Yang X, Ou M, Chen Y, Gan D. PMID: 42889514 [PubMed]
	Successful management of synchronous prostate adenocarcinoma and lung squamous cell carcinoma with sintilimab and ADT in a frail elderly patient with bronchiectasis: a case report. Front Immunol Huang Y, Zhan W, Su T, Liu Y. PMID: 42889325 [PubMed - indexed for MEDLINE]
	NEITHER study: NICE versus EAU inconsistent triage, expenses and reliability in non-high-risk non-muscle invasive bladder cancer surveillance. BJUI Compass Ibrahim Y, Ribeiro L, Heelan M, Spazzapam M, Macaskill F, Fernando K, Ahmed A, Hussien A, Gad M, Chakravarti S, Mokbel S, Nair R, Thurairaja R, Khan MS, Abughanem Y, Mensah E. PMID: 42889172 [PubMed]
	Integrated network toxicology, transcriptomic, and Mendelian randomization analyses explore potential molecular links between acrylamide exposure and clear cell renal cell carcinoma. Medicine (Baltimore) Deng S, Wang S, Zeng Z, Li T, Zou L, Zhou Y, Lei L, Zhou T. PMID: 42888631 [PubMed - indexed for MEDLINE]
	Diagnosis of prostate cancer by multi-modal ultrasound imaging. Medicine (Baltimore) Li J, He K, Zhang H, Hu D, Wei X, Luo L. PMID: 42888615 [PubMed - indexed for MEDLINE]
	Development and validation of a ferroptosis and metabolic reprogramming gene signature for risk stratification in bladder urothelial carcinoma: A retrospective multicohort study. Medicine (Baltimore) Ma Y, Zhang Z, Tang L, Li Q, Zhao Y. PMID: 42888597 [PubMed - indexed for MEDLINE]
	Investigation on Automatic Classification of Bone, Lymph Node, and Local Lesions in CT Images of Prostate Cancer Patients. J Imaging Inform Med Rainio O, Vehmanen A, Li A, Jaakkola MK, Kemppainen J, Klén R. PMID: 42888311 [PubMed - as supplied by publisher]
	Active Surveillance for Intermediate-risk Prostate Cancer: Implications of AI-enabled Pattern Quantification. Eur Urol Focus Mittmann G, van den Bergh RCN, Fine SW, Vickers AJ, Brinker TJ. PMID: 42888115 [PubMed - as supplied by publisher]
	MicroRNAs in prostate cancer radioresistance: mechanisms, target-based network analysis and translational opportunities. Exp Mol Pathol Ferreira I, Ferreira M, Medeiros R, Teixeira AL. PMID: 42887484 [PubMed - as supplied by publisher]
	Plasma-Derived Genomic Instability Status and Rucaparib Outcomes in Metastatic Castration-Resistant Prostate Cancer: TRITON2. JCO Precis Oncol Abida W, Bryce AH, Chowdhury S, Patnaik A, Overstreet B, Margolis M, Safabakhsh P, Fizazi K. PMID: 42886888 [PubMed - indexed for MEDLINE]
	Management of extravasations of enfortumab vedotin and pembrolizumab: a case report and mini review of the current literature. J Cancer Res Clin Oncol Dinkel H, Seifert KE, Bögemann M, Schrader AJ, Schlack K. PMID: 42886339 [PubMed - indexed for MEDLINE]
	Risk-adapted MRI Protocols for the Detection of Clinically Significant Prostate Cancer. Radiol Imaging Cancer Ponsiglione A, Cereser L, De Martino M, Bacchetti E, Cirillo M, Cuocolo R, Di Costanzo G, Stanzione A, Brembilla G, Pecoraro M, Dias AB, Gutierrez PA, Hernández-Mancera J, Messina E, Russo L, Cannella R, Ascione R, Borgheresi A, Zuiani C, Crestani A, Giannarini G, Panebianco V, Padhani AR, Imbriaco M, Girometti R. PMID: 42886040 [PubMed - indexed for MEDLINE]
	Enhanced detection of bladder cancer using machine learning analysis of routine urinary sediment data. Clin Chem Lab Med Okuyama R, Horiuchi H, Nakamura M, Muroya M, Morikawa T. PMID: 42885914 [PubMed - as supplied by publisher]
	Effects of Decision Support Interventions on Treatment Decision-Making in Patients With Prostate Cancer: A Systematic Review and Network Meta-Analysis. Asia Pac J Clin Oncol Wen Y, Li Y, Zheng S, Li J, Huang X, Zhang Y, Jin Y. PMID: 42885513 [PubMed - as supplied by publisher]
	General versus site specific quantile random forest models for virtual patient-specific quality assurance of VMAT plans. J Appl Clin Med Phys Rahman N, Kaliel G, D'Souza M, Yamabe Breitkreutz D. PMID: 42885344 [PubMed - indexed for MEDLINE]
	Navigating the landscape of targeted therapies for renal cell carcinoma in the era of precision medicine (Review). Mol Med Rep Cui H, Song J, Yang P, Zhang Z, Liu Y, Zhang G, Tian A, Che J, Liu Y, Sun H, Xu Y. PMID: 42885310 [PubMed - indexed for MEDLINE]
	Soy Consumption and the Risk of Developing Bladder Cancer: A Pooled Analysis of Cohort Studies from the International Pooled Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study. Nutrients Wu YW, Yu EY, Chen YT, Li MH, Liang YT. PMID: 42884561 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 182238

Page 1 of 9112



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy